vTv Therapeutics (VTVT) Return on Invested Capital (2017 - 2024)
Historic Return on Invested Capital for vTv Therapeutics (VTVT) over the last 7 years, with Q4 2024 value amounting to 1.51%.
- vTv Therapeutics' Return on Invested Capital changed N/A to 1.51% in Q4 2024 from the same period last year, while for Dec 2024 it was 1.51%, marking a year-over-year change of. This contributed to the annual value of 4.68% for FY2024, which is N/A changed from last year.
- As of Q4 2024, vTv Therapeutics' Return on Invested Capital stood at 1.51%.
- vTv Therapeutics' 5-year Return on Invested Capital high stood at 2.83% for Q2 2022, and its period low was 36.41% during Q1 2024.
- Moreover, its 4-year median value for Return on Invested Capital was 0.26% (2021), whereas its average is 2.18%.
- Its Return on Invested Capital has fluctuated over the past 5 years, first crashed by -2800bps in 2021, then surged by 26400bps in 2022.
- vTv Therapeutics' Return on Invested Capital (Quarter) stood at 0.42% in 2020, then skyrocketed by 231bps to 1.39% in 2021, then rose by 19bps to 1.66% in 2022, then tumbled by -191bps to 1.51% in 2024.
- Its Return on Invested Capital stands at 1.51% for Q4 2024, versus 1.26% for Q3 2024 and 0.99% for Q2 2024.